Cleerly

Description

Developer of a healthcare platform designed to create a new standard of care for coronary artery disease. The company's platform has a non-invasive, AI-driven approach that supports the understanding of plaques and offers comprehensive quantification and characterization of plaque buildup in the heart arteries, enabling healthcare providers to drastically improve the identification of at-risk patients for early treatment and prevention of heart attacks in a cost-effective manner.

Founded

2017

Headquarters

101 Greenwich St

New York,10006
New York

Company Products 1